Background Cutaneous Human Papillomavirus (HPV) types have been associated with non-
Introduction
Immunosuppression greatly raises the risk for non-melanoma skin cancer. Activation of oncogenic skin viruses has been proposed as a possible explanation. Cutaneous papillomaviruses infect healthy skin and are found in skin lesions such as actinic keratosis (AK) and squamous cell carcinoma of the skin (SCC) (1) . Prospective HPV seroepidemiology has been instrumental in providing prospective evidence supporting the causal association between HPV and cervical, anogenital and oropharyngeal cancers (2) .
Previously, we reported weak associations between HPV types 3, 15, 38 and 76 and future risk of SCC (3) . The previous study was carried out using an HPV serological method (GST-L1 fusion proteins) that has only weak association with HPV infection (4) . Using a conformational HPV antigen (pseudovirions), HPV serology shows a better correlation to HPV infection (4) . To use the improved HPV serology for a large prospective study is therefore likely to be more informative regarding any possible role of HPV in skin cancer.
Materials and methods

Cohorts and study design
The cohorts and the study design are previously described (3). One matched control was selected for each case. We could include 633 SCC cases with 3115 samples and 1990 BCC cases with 6145 samples and the same numbers of controls. In the serial-samples analysis, there were 531 BCC and 256 SCC cases (and the same numbers of controls) that had at least 2 pre-diagnostic samples,
HPV serology using Pseudovirions
Serology was performed as described (5 and JC polyomaviruses (JCPyV) were included(4). Cut-off values to define seropositivity were calculated independently for each HPV type by analysing the mean fluorescence intensity unit (MFI) values obtained from 141 childrens' sera (average 4 years old). The cutoff algorithm recommended by the global HPV LabNet (6) (mean MFI value of a negative control serum panel plus 3 standard deviations) was used, except that the cut-off had to be at least 250 MFI.
Statistics
Relative risks were estimated as odds ratios and 95% confidence intervals by means of conditional logistic regression with SAS 9.4 software (SAS Institute, Inc., Cary, NC). If the asymptotic model did not converge, median unbiased estimates of ORs were estimated by exact conditional logistic regression. Heterogeneity in the OR estimates was assessed with a likelihood ratio test.
Results
Seropositivity at baseline showed no association to future risk for SCC for any of the tested and persistent seropositivity to HPV-15 and the HPV beta-2 group was weakly associated with BCC risk (OR=1.4 95%CI 1.0-1.9) and (OR=1.4 95%CI 1.1-2.0), respectively) (Table   2b ).
Discussion
We report a large, prospective HPV serological study with improved methodology to assess possible associations between HPV infections and future non-melanoma skin-cancer, as has been reported previously (3) . In the present study, we found exactly the same result for HPV-15 and the HPV beta-2 group as in the previous study regarding association with BCC development if seropositive at baseline and for HPV-15 if persistently seropositive. The previously reported associations between HPV-3, 38, 76 or the beta-2 group and SCC (3) were not found in the present study.
All statistically significant associations were very weak and, considering the large number of viruses analysed, might thus be attributable to chance. The strongest association was seen for acquired HPV-5 seropositivity and future SCC risk. In 2012, IARC classified HPV-5 as having "limited evidence" for carcinogenicity, mostly based on data from the epidermodysplasia verruciformis disease (7). We find that HPV-5 may be involved in skin SCC, also in the general population.
A majority of studied HPV types were genital/mucosal and were included as negative controls.
Persistent seropositivity for HPV-6 was weakly associated with future SCC, most likely attributed to chance. As we only studied four different HPV types in the beta group, we cannot conclude that all cutaneous HPV are harmless. For example, a recently discovered HPV type (HPV-197) has been reported in a rather large proportion of SCC (8 
